CIK 0001001316
- Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363898269
- Phone
- +1 212-554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- 4 Grant or award Director acquired 27,048 shares (grant or award)
- 4 Grant or award Director acquired 27,048 shares (grant or award)
- 4 Grant or award Director acquired 27,048 shares (grant or award)
- 4 Grant or award Director acquired 27,048 shares (grant or award)
- 4 Grant or award Director acquired 27,048 shares (grant or award)
- 4 Open-market sale CFO, Secretary and Treasurer sold 17,654 shares at $8.47 ($149,529)
- 4 Open-market buy CEO and President bought 50,000 shares at $7.04 ($351,750)
- 4 Grant or award CEO and President acquired 1,179,380 shares (grant or award)
- 4 Open-market sale CFO, Secretary and Treasurer sold 37,275 shares at $4.13 ($153,946)
- 4 Open-market sale CFO, Secretary and Treasurer sold 47,191 shares at an average $13.21 ($623,303)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award CEO and President acquired 1,018,011 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Open-market sale Director sold 25,071 shares at $13.45 ($337,205)
- 4 Open-market sale CFO, Secretary and Treasurer sold 32,006 shares at $8.50 ($272,051)
- 4 Grant or award CEO and President acquired 834,877 shares (grant or award)
Page 5 of 18 · 353 filings